magbo system

The ensoETM [Image from Attune Medical] Attune Medical announced today that the FDA granted investigational device exemption (IDE) to study the company’s ensoETM. Chicago-based Attune designed ensoETM to reduce esophageal thermal injury during cardiac radiofrequency (RF) ablation procedures. The IMPACT II study is underway in Europe and already enrolled nearly 20 patients. Attune said in…